Bioinformatics-Based Analysis of the Screening and Evaluation of Potential Targets of FTY720 for the Treatment of Non-Small Cell Lung Cancer
Our research indicates that FTY720 may inhibit NSCLC via possible targets ZEB2 and S1PR1, further laying the theoretical foundation for the utilization of FTY720 in NSCLC treatment.
Authors
- Sendaer Hailati (ORCID: https://orcid.org/0000-0001-5867-8744)
- Dilihuma Dilimulati (ORCID: https://orcid.org/0009-0004-9690-4350)
- Mengyuan Han (ORCID: https://orcid.org/0000-0003-4145-1820)
- Wenting Zhou (ORCID: https://orcid.org/0000-0003-2610-7634)
- Alhar Baishan
- Alifeiye Aikebaier
Institutions
- Xinjiang Medical University (CN)
- Xinjiang Technical Institute of Physics & Chemistry (CN)
- Heze Municipal Hospital (CN)
Publication Details
- Journal
- Biology
- Published
- 2025-09-23
- DOI
- https://doi.org/10.3390/biology14101311
- Primary Topic
- PI3K/AKT/mTOR signaling in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Science Fund for Distinguished Young Scholars of Xinjiang Autonomous Region